PCI

Yuxuan Zhang1, Jiacheng Fang1, Zining Chen1

  • 1Department of Cardiology of The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, China; Cardiovascular Key Laboratory Zhejiang Province, Hangzhou, China; Transvascular Implant Instrument Research Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine, Binjiang District, Hangzhou, China.

PubMed
概括

穿皮冠状动脉干预 (PCI) 后血管学衍生微循环阻力指数 (Δangio-IMR) 的升高变化预测了目标血管衰竭 (TVF) 的更高风险. 高DANGIO-IMR是中级冠状动脉狭窄症患者风险分层的一个有价值的指标.